Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 41

Trial Status

Completed5
Terminated1
Other1

Role Distribution

Principal Investigator6
Other Roles1
PI Rate86%

Activity Timeline

Clinical Trials (7)

NCT05010707Phase 2Completed
Transgender Estradiol Affirming Therapy
Transgenderism
PrincipalinvestigatorStart date: 2021-08-02
NCT03980743Not ApplicableCompleted
Interactive Obesity Treatment Approach for Obesity Prevention in Adults With Early Serious Mental Illness: iOTA-SMI
ObesityOverweightSevere Mental Disorder
PrincipalinvestigatorStart date: 2020-07-15
NCT02717130Not ApplicableTerminated
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
Schizophrenia
PrincipalinvestigatorStart date: 2016-06-08
NCT00205699Phase 4Completed
Metabolic Effects of Antipsychotics in Children
AggressionAttention Deficit-HyperactivityBipolar Disorder+2 more
StudydirectorStart date: 2006-04-01
NCT00836251Completed
Effects of Antipsychotic Medications on Energy Intake and Expenditure
Schizoaffective DisorderSchizophreniaWeight Gain
Principalinvestigator
NCT00910988Not ApplicableCompleted
Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone
HyperglycemiaHyperlipidemia
Principalinvestigator
NCT05675800Phase 2Withdrawn
Psilocybin for Major Depressive Disorder
Major Depressive Disorder
Principalinvestigator

Research Network

Collaboration Network

5 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

John W. Newcomer, MD

Florida Atlantic University and Washington University School of Medicine

Similar
1 trials

Shared therapeutic areas:

AggressionAttention Deficit-HyperactivityBipolar Disorder+2 more

Worked with same sponsors:

National Institute of Mental Health (NIMH)Washington University School of Medicine
Collaborated on 1 trial
Similarity Score54%

John W Newcomer, MD

Florida Atlantic University

Moderately Similar
1 trials

Shared therapeutic areas:

Schizoaffective DisorderSchizophreniaWeight Gain

Worked with same sponsors:

Washington University School of Medicine
Collaborated on 1 trial
Similarity Score34%

John W Newcomer, MD

Washington University School of Medicine and Florida Atlantic University

Related
2 trials

Shared therapeutic areas:

HyperglycemiaHyperlipidemias

Worked with same sponsors:

PfizerWashington University School of Medicine
Collaborated on 1 trial
Similarity Score24%

John Newcomer, MD

Florida Atlantic University

Related
1 trials

Shared therapeutic areas:

Schizophrenia

Worked with same sponsors:

Burrell Behavioral HealthFlorida Atlantic University+3 more
Collaborated on 1 trial
Similarity Score14%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Bipolar DisorderMajor Depressive DisorderObesity
Similarity Score6%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

OverweightHyperlipidemiasObesity
Similarity Score6%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score4%

Urielle Desalbres

Assistance Publique Hôpitaux de Marseille

Related
71 trials

Shared therapeutic areas:

Bipolar DisorderSchizophrenia
Similarity Score4%

Jack A Yanovski, M.D.

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Related
23 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score4%

Lisa Porter, MD

Amylin Pharmaceuticals, LLC.

Related
19 trials

Shared therapeutic areas:

ObesityOverweight
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (7)

Showing 7 of 7 trials

NCT05010707Phase 2PrincipalInvestigator

Transgender Estradiol Affirming Therapy

Transgenderism
Completed
NCT03980743Not ApplicablePrincipalInvestigator

Interactive Obesity Treatment Approach for Obesity Prevention in Adults With Early Serious Mental Illness: iOTA-SMI

ObesityOverweightSevere Mental Disorder
Completed
NCT02717130Not ApplicablePrincipalInvestigator

Aripiprazole, Abilify Maintena Collaborative Clinical Protocol

Schizophrenia
Terminated
NCT00205699Phase 4StudyDirector

Metabolic Effects of Antipsychotics in Children

AggressionAttention Deficit-HyperactivityBipolar Disorder+2 more
Completed
NCT00836251PrincipalInvestigator

Effects of Antipsychotic Medications on Energy Intake and Expenditure

Schizoaffective DisorderSchizophreniaWeight Gain
Completed
NCT00910988Not ApplicablePrincipalInvestigator

Healthy Volunteers Study of the Effects of Olanzapine and Ziprasidone

HyperglycemiaHyperlipidemia
Completed
NCT05675800Phase 2PrincipalInvestigator

Psilocybin for Major Depressive Disorder

Major Depressive Disorder
Withdrawn

All 7 trials loaded